Average Co-Inventor Count = 8.57
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Infinity Pharmaceuticals, Inc. (6 from 108 patents)
2. Infinity Discovery, Inc. (4 from 12 patents)
3. Biogen Ma Inc. (3 from 250 patents)
4. Eisai R&d Management Co., Ltd. (1 from 529 patents)
5. James R. Porter (0 patent)
6. Michael A. Foley (0 patent)
7. Alfredo Castro (0 patent)
8. Martin Tremblay (0 patent)
9. Julian Adams (0 patent)
10. Somarajan Nair Janardanan Nair (0 patent)
11. Marta Nevalainen (0 patent)
14 patents:
1. 12391697 - Condensed bi-heterocycles as inhibiting agents for Bruton's tyrosine kinase
2. 12240838 - Inhibiting agents for Bruton's tyrosine kinase
3. 11926619 - Certain pladienolide compounds and methods of use
4. 10899753 - Inhibiting agents for Bruton's tyrosine kinase
5. 9346769 - Tetrazolones as inhibitors of fatty acid synthase
6. 8609706 - Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
7. 8546432 - Tetrazolones as inhibitors of fatty acid synthase
8. 8450350 - Triazoles as inhibitors of fatty acid synthase
9. 8236956 - Cyclopamine analogues and methods of use thereof
10. 8178690 - Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
11. 7928244 - Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
12. 7875628 - Cyclopamine analogues and methods of use thereof
13. 7407967 - Cyclopamine analogues and methods of use thereof
14. 7230004 - Cyclopamine analogues and methods of use thereof